1. Home
  2. SAM vs MLTX Comparison

SAM vs MLTX Comparison

Compare SAM & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Beer Company Inc. (The)

SAM

Boston Beer Company Inc. (The)

HOLD

Current Price

$163.81

Market Cap

1.9B

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$12.07

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAM
MLTX
Founded
1984
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
SAM
MLTX
Price
$163.81
$12.07
Analyst Decision
Hold
Buy
Analyst Count
11
12
Target Price
★ $233.70
$27.50
AVG Volume (30 Days)
169.7K
★ 1.5M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 95.45
N/A
EPS
N/A
★ N/A
Revenue
★ $1,964,994,000.00
N/A
Revenue This Year
$1.02
N/A
Revenue Next Year
$1.31
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$158.68
$5.95
52 Week High
$264.46
$23.29

Technical Indicators

Market Signals
Indicator
SAM
MLTX
Relative Strength Index (RSI) 35.00 30.51
Support Level $162.58 $11.88
Resistance Level $189.24 $19.24
Average True Range (ATR) 6.57 0.78
MACD -0.32 0.05
Stochastic Oscillator 22.61 7.16

Price Performance

Historical Comparison
SAM
MLTX

About SAM Boston Beer Company Inc. (The)

Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: